Drugs
Senate Drug Manufacturing Transparency Bill Watered Down
A bipartisan Senate bill intended to give patients and health care providers more information about where prescription drugs are manufactured has lost two provisions that drug safety experts considered important to making the new disclosure requirements effective, according to ProPublica. The bill, the Consumer Labeling for Enhanced API Reporting and